DXRX — Diaceutics Income Statement

0.000.00%

Last trade - 00:00

IndustrialsAdventurousSmall CapHigh Flyer

Annual income statement for Diaceutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	C2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	13.9	19.5	23.7	32.2	38.4
Cost of Revenue
Gross Profit	12.2	16.7	19.7	28.3	31.5
Selling / General / Administrative Expenses
Other Operating Expenses
Total Operating Expenses	13.4	18.9	26.7	34.6	38.4
Operating Profit	0.55	0.575	-3.02	-2.46	0.043
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	0.462	0.564	-2.44	-1.91	0.302
Provision for Income Taxes
Net Income After Taxes	0.561	0.724	-1.75	-1.7	0.097
Net Income Before Extraordinary Items
Net Income	0.561	0.724	-1.75	-1.7	0.097
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	0.561	0.724	-1.75	-1.7	0.097
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.007	0.008	-0.021	-0.019	0.001